Showing results (1021-1030 of 1,205) with videos related to

Sort By:
Pageof 121
Gene Therapy|March 18, 2011
Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL geneX Cao, M Yang, R-C Wei, et al.
Frontiers in Oncology|March 9, 2026
Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot studyEllis L Eikenboom, Joséphine Magnin, Remo Alessandris, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
ESMO Open|June 28, 2023
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trialJ Rodon Ahnert, D S-W Tan, I Garrido-Laguna, et al.
BMJ Open|June 22, 2022
Functional Improvement Trajectories After Surgery (FIT After Surgery) study: protocol for a multicentre prospective cohort study to evaluate significant new disability after major surgery in older adultsDuminda N Wijeysundera, Shabbir M H Alibhai, Karim S Ladha, et al.
JAMA Oncology|September 1, 2022
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical TrialThierry Conroy, Florence Castan, Anthony Lopez, et al.
Annals of Surgery|October 5, 2023
Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current TreatmentAlessandra Pulvirenti, Ammar A Javed, Theodoros Michelakos, et al.
JCO Oncology Practice|December 20, 2024
Impact of Financial Toxicity on Treatment Adherence and Quality of Life in Pancreatic CancerLauren E Schleimer, Emeline Aviki, Hannah L Kalvin, et al.
JCO Precision Oncology|October 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and SurvivalPratik Chandra, Yi Song, Esther Drill, et al.
Clinical Pharmacology and Therapeutics|September 27, 2024
A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular LymphomaChi-Chung Li, Brendan Bender, Justin Wilkins, et al.
Pageof 121